Krystal Biotech EBITDA 2017-2024 | KRYS
- Krystal Biotech 2023 EBITDA was -0.106B, a 24.9% decline from 2022.
- Krystal Biotech 2022 EBITDA was -0.141B, a 115.46% increase from 2021.
- Krystal Biotech 2021 EBITDA was -0.066B, a 110.31% increase from 2020.
EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.